Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
InChi: InChI=1S/C33H42O12/c1-16-21(42-17(2)34)14-33(40)28(44-29(39)20-11-9-8-10-12-20)26-31(7
Cimifugin is a bioactive component of Saposhnikovia divaricata
A66 blocks phosphoinositide 3-kinase signalling and tumour growth in certain cell types
J Cell Biochem
anti-virus
MK-3697 p-016 InChi: InChI=1S/C33H42O12/c1-16-21(42-17(2)34)14-33(40)28(44-29(39)20-11-9-8-10-12-20)26-31(7MK 3697 is a highly potent, orally bioavailable selective orexin 2 receptor antagonists . MK 3697 is also the third insomnia drug, currently being developed by Merck. MK 3697 has Ki = 0. 95 nM. Orexin receptor antagonists have demonstrated clinical utility for the treatment of insomnia. In vivo tests results on MK 3697 demonstrated improved stability and TDI profiles as well as excellent sleep efficacy across species. Product information CAS Number:
US$ 19.99
US$ 16.50
US$ 14.99
US$ 39.99
US$ 19.80